|
William A. Banks, MD - Saint Louis University School
of Medicine |
|
Neil
Buckholtz, PhD - National Institute on Aging |
|
Henry R. Costantino, PhD - Nastech Pharmaceutical
Company Inc. |
|
Richard DiRocco, PhD - Secant Pharma |
|
Howard Fillit, MD - ADDF |
|
William H. Frey II, PhD - University of Minnesota &
Regions Hospital |
|
Marcie Glicksman, PhD - Harvard Medical School |
|
Illana Gozes, PhD - Allon Therapeutics and Tel Aviv
University |
|
Oppel Greeff, MD - Quintiles International |
|
Barry D. Greenberg, PhD –
Neurochem, Inc. |
|
Richard K. Harrison, PhD - Vitae Pharmaceuticals |
|
Christopher A. Lipinski, PhD – Melior Discovery |
|
Dale Lombardi, PhD - Secant Pharma |
|
Elias Michaelis, MD, PhD - University of Kansas |
|
Richard C. Mohs, PhD - Eli Lilly and Company |
|
J.
Fred Pritchard, PhD, MDS - Pharma Services |
|
Lorenzo Refolo, PhD - National Institute of
Neurological Disorders and Stroke |
|
Barbara Sahagan, PhD - Pfizer, Inc |
|
F.
Raymond Salemme, PhD - Redpoint Bio Corporation |
|
Dale
B. Schenk, PhD - Elan Pharmaceuticals |
|
Peter Schüler, MD, MPM - PRA International |
|
Gabriel A. Silva, MSc, PhD - University of
California, San Diego |
|
Edward Spack, PhD - SRI International |
|
Ross
Stein, PhD -
Harvard Medical School & Brigham and Women’s Hospital |
|
Jordan Tang, PhD - Oklahoma Medical Research
Foundation |
|
Manfred Windisch, PhD - JSW-Research |
|
Linda Van Eldik, PhD -
Northwestern University |
|
D.
Martin Watterson, PhD - Northwestern University |
|
Camille G. Wermuth, PharmD, PhD - Université Pasteur
and Strasbourg & Prestwick Chemical, Inc |
|
Michael W. Weiner, MD - University of California, San
Francisco |
|
Lawrence M. Zaccaro - Pfizer, Inc.
|
|
John
Zawad, PhD - University of Pennsylvania |
